Stocks Overview

LAST PRICE
38.1400
TODAY'S CHANGE (%)
Trending Up1.3700 (3.7259%)

Bid / Lots
36.9300/ 1
Ask / Lots
39.4200/ 1
Open / Previous Close
37.1000 / 36.7700
Day Range
Low 36.6000
High 38.3100
52 Week Range
Low 18.0000
High 53.9200
Volume
412,791
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 36.77
Time	Volume	SWTX
09:32 ET	3426	36.93
09:34 ET	1359	36.855
09:36 ET	1799	36.68
09:38 ET	800	37.11
09:39 ET	300	37.005
09:41 ET	2608	36.845
09:43 ET	100	36.67
09:45 ET	500	36.71
09:48 ET	100	36.72
09:50 ET	818	36.685
09:52 ET	800	36.765
09:54 ET	662	36.85
09:56 ET	500	37.07
09:59 ET	1537	37.17
10:01 ET	1600	37.2
10:03 ET	904	37.19
10:06 ET	478	37.43
10:08 ET	100	37.26
10:10 ET	660	37.345
10:12 ET	1800	37.37
10:14 ET	5913	37.35
10:15 ET	1100	37.55
10:17 ET	600	37.45
10:19 ET	400	37.41
10:21 ET	100	37.39
10:24 ET	2005	37.71
10:26 ET	800	37.79
10:28 ET	849	37.76
10:30 ET	764	37.9
10:32 ET	300	37.84
10:33 ET	500	37.895
10:35 ET	200	37.88
10:37 ET	1300	37.77
10:39 ET	800	37.88
10:42 ET	1300	37.79
10:44 ET	1800	37.78
10:46 ET	300	37.76
10:48 ET	1619	37.91
10:50 ET	500	37.97
10:51 ET	400	38.04
10:53 ET	342	38.09
10:55 ET	300	38.015
10:57 ET	361	37.96
11:00 ET	2505	38.11
11:02 ET	1115	37.88
11:04 ET	800	37.9
11:06 ET	400	37.95
11:08 ET	100	37.94
11:09 ET	300	37.875
11:11 ET	500	37.71
11:13 ET	586	37.61
11:15 ET	938	37.69
11:20 ET	600	37.56
11:22 ET	360	37.45
11:24 ET	200	37.51
11:26 ET	200	37.48
11:27 ET	300	37.34
11:29 ET	1792	37.34
11:31 ET	1700	37.33
11:33 ET	4574	37.33
11:36 ET	3270	37.2405
11:38 ET	700	37.24
11:40 ET	700	37.18
11:42 ET	200	37.235
11:44 ET	793	37.23
11:45 ET	200	37.205
11:47 ET	200	37.27
11:49 ET	648	37.28
11:51 ET	200	37.285
11:56 ET	477	37.2
11:58 ET	600	37.17
12:00 ET	243	37.15
12:02 ET	3848	37.22
12:05 ET	800	37.33
12:07 ET	1047	37.32
12:09 ET	200	37.26
12:12 ET	1134	37.28
12:14 ET	100	37.32
12:16 ET	935	37.405
12:18 ET	100	37.37
12:20 ET	255	37.3724
12:23 ET	200	37.355
12:25 ET	100	37.32
12:27 ET	800	37.39
12:30 ET	514	37.47
12:32 ET	100	37.43
12:36 ET	700	37.47
12:38 ET	600	37.61
12:39 ET	300	37.58
12:43 ET	1900	37.71
12:45 ET	800	37.925
12:48 ET	500	37.945
12:50 ET	608	37.86
12:52 ET	100	37.895
12:54 ET	600	38.03
12:57 ET	200	38.02
12:59 ET	800	37.96
01:01 ET	400	37.96
01:03 ET	1015	37.955
01:06 ET	300	37.87
01:08 ET	100	37.89
01:10 ET	639	37.87
01:12 ET	936	37.73
01:14 ET	730	37.76
01:15 ET	400	37.64
01:21 ET	725	37.71
01:24 ET	400	37.66
01:26 ET	300	37.695
01:28 ET	800	37.705
01:30 ET	981	37.67
01:32 ET	962	37.76
01:33 ET	100	37.82
01:35 ET	1200	37.905
01:42 ET	1100	37.91
01:44 ET	800	37.88
01:46 ET	2224	37.925
01:48 ET	598	37.85
01:50 ET	348	37.86
01:51 ET	834	37.9
01:53 ET	100	37.905
01:55 ET	1240	37.94
01:57 ET	200	37.99
02:00 ET	700	38.005
02:02 ET	859	37.915
02:04 ET	717	38
02:06 ET	871	38.005
02:08 ET	1206	38.09
02:09 ET	300	38.085
02:11 ET	2632	38.2
02:13 ET	300	38.15
02:15 ET	1350	38.135
02:18 ET	100	38.135
02:20 ET	1747	38.17
02:22 ET	1200	38.22
02:24 ET	1000	38.31
02:26 ET	426	38.29
02:27 ET	1200	38.23
02:29 ET	1299	38.24
02:31 ET	1257	38.25
02:33 ET	1096	38.24
02:36 ET	401	38.21
02:38 ET	500	38.21
02:40 ET	286	38.185
02:42 ET	1555	38.29
02:44 ET	600	38.2
02:45 ET	903	38.17
02:47 ET	1200	38.215
02:51 ET	100	38.205
02:54 ET	1129	38.17
02:56 ET	500	38.1
02:58 ET	1700	38.115
03:00 ET	100	38.115
03:02 ET	560	38.05
03:03 ET	1202	38.08
03:05 ET	1530	38.115
03:07 ET	900	38.13
03:09 ET	200	38.08
03:12 ET	500	38.065
03:14 ET	1344	38.06
03:16 ET	600	38.065
03:18 ET	400	38.14
03:20 ET	416	38.105
03:23 ET	200	38.095
03:25 ET	300	38.095
03:27 ET	400	38.09
03:30 ET	2757	38.11
03:32 ET	1889	38.24
03:34 ET	500	38.29
03:36 ET	1183	38.225
03:38 ET	500	38.18
03:39 ET	1800	38.12
03:41 ET	2104	38.12
03:43 ET	100	38.115
03:45 ET	2200	38.11
03:48 ET	700	38.1
03:50 ET	2281	38.12
03:52 ET	4028	38.21
03:54 ET	1300	38.215
03:56 ET	6723	38.07
03:57 ET	8199	38
03:59 ET	18845	38.14

Data delayed at least 15 minutes.

Jul 2, 2024
- Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm, from 12:49PM ET on Tuesday Jul 02, 2024 by Dow Jones
  12:49PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jul 1, 2024
- SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN, from 6:30AM ET on Monday Jul 01, 2024 by Dow Jones
  6:30AM ET on Monday Jul 01, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSWTX SpringWorks Therapeutics Inc	2.7B	-7.4x	---
United StatesGERN Geron Corp	2.7B	-13.1x	---
United StatesMLTX MoonLake Immunotherapeutics	2.7B	-58.0x	---
United StatesXENE Xenon Pharmaceuticals Inc	2.8B	-13.7x	---
United StatesIDYA IDEAYA Biosciences Inc	2.6B	-19.8x	---
United StatesBHVN Biohaven Ltd	3.0B	-5.0x	---
As of 2024-07-08

SpringWorks Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer. OGSIVEO (nirogacestat) is the Company's Food and Drug Administration (FDA)-approved therapy. OGSIVEO (nirogacestat) is approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment. The Company also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. Its ongoing developments include Nirogacestat for treatment of ovarian granulosa cell tumors, Nirogacestat in combination with B-cell maturation antigen (BCMA)-targeted agents, Mirdametinib Phase 2b ReNeu trial in NF1-PN and Brimarafenib (BGB-3245). The Company's early-stage pipeline includes SW-682, an investigational oral, small molecule TEA Domain (TEAD), inhibitor that is evaluated in Hippo-mutant solid tumors.

Contact Information

Headquarters: 100 Washington BlvdSTAMFORD, CT, United States 06902-9302
Phone: 203-883-9490
Fax: 302-655-5049

Executives

Independent Chairman of the Board: Daniel Lynch
Chief Executive Officer, Director: Saqib Islam
Chief Financial Officer: Francis Perier
Chief Operating Officer: Badreddin Edris
Chief People Officer: Daniel Pichl

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.7B
Revenue (TTM)	$26.5M
Shares Outstanding	74.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.78
EPS	$-5.15
Book Value	$8.52
P/E Ratio	-7.4x
Price/Sales (TTM)	103.0
Price/Cash Flow (TTM)	---
Operating Margin	-1,358.05%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

SpringWorks Therapeutics Inc
NASDAQ:SWTXUnited States

Search Criteria

Charts

Recent News

Jul 2, 2024

Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm, from 12:49PM ET on Tuesday Jul 02, 2024 by Dow Jones

Jul 1, 2024

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN, from 6:30AM ET on Monday Jul 01, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar